Principals

Partner

Paul Stewart

Paul Stewart was a partner in the international law firm Baker & McKenzie, handling matters before the FDA and other government agencies as well as general business transactions, before taking an offer to lead the U.S. operations of the Leibinger companies, a global medical device business based in Germany. With close involvement and supervision by Stewart, Leibinger developed and launched numerous pioneering new products that revolutionized craniofacial and neurosurgical procedures. Stewart led the sale of Leibinger to Pfizer and then continued to lead Leibinger’s operations, as well as serving on the Management Board of Pfizer’s large orthopedic subsidiary. Stewart was then involved in a venture capital firm investing in early stage healthcare companies, and was co-founder of several businesses in the healthcare field. In 2013, Stewart joined Frank Murdock to help develop the Tranexamic Technologies business. He is a co-inventor in 7 patent filings relating to the TXCAs. Stewart has extensive experience organizing and managing complex development projects involving leading scientists from universities and private labs, contractors, government agencies, regulators, investors and business partners.

Partner

Frank Murdock

Frank Murdock has over 30 years experience in sales, marketing and product development of a broad range of innovative surgical, therapeutic and medicinal/pharmaceutical products. Led the global Neuroscience Division of the Leibinger companies before and after the Pfizer acquisition. He then led Sales and Marketing and Clinical Affairs for Image Guided Neurologics (acquired by Medtronic). Murdock became involved with the initial company in the Tranexamic Technologies group as an investor, and then as an inventor of the core technologies involving new applications of TA including antiviral, anti-aging and treatment of concussions. He brings the group his extensive knowledge of TA, as well as his long experience in developing and launching new medical products and working closely with clinicians, university collaborators, and commercial partners. He is the inventor or co-inventor of 15 issued patents with multiple pending.